Ohta, Tsuyoshi
Sugimoto, Masahiro
Ito, Yasufumi
Horikawa, Shota
Okui, Yosuke
Sakaki, Hirotsugu
Seino, Manabu
Sunamura, Makoto
Nagase, Satoru
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K09509)
Japan Society for the Promotion of Science (21K09532)
Article History
Received: 25 January 2024
Accepted: 11 September 2024
First Online: 16 September 2024
Competing interests
: Masahiro Sugimoto received annual value of remuneration from Saliva Tech Co. Ldt. and Human Metabolome Technologies Inc. Masahiro Sugimoto and Makoto Sunamura received annual profit from share from Saliva Tech Co. Ldt. The other authors declare no conflict of interest.
: The study protocol was approved by the Ethics Committee of Yamagata University School of Medicine (2019 − 385). All informed consent was obtained from each participant prior to participation in the study.